Boosting Cancer Immunotherapy With Next Generation Co-Cultured Product
Time: 2:15 pm
day: Day 1 Track A PM
Details:
- Outlining MET-C product generation, driven by predictive AI and by state-of-the-art proprietary in vitro and in vivo validation
- Presenting preclinical data for ground-breaking co-culture donor independent for first MaaT03X asset, a full synthetic microbiome capsule
